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Abstract
Aflatoxins constitute a cluster of mycotoxins that are derived from fungal metab-
olites and are produced from diverse fungi species, especially Aspergillus. They are a 
collection of closely linked heterocyclic compounds produced predominantly by two 
filamentous fungi, Aspergillus flavus and Aspergillus parasiticus. They are also known 
to cause severe health threats to humans and animals, thereby resulting to several 
complications like immunotoxicity, teratogenicity hepatotoxicity. Aflatoxins inter-
fere with normal metabolic processes. This interference encompasses the regulatory 
processes that occur throughout the progression of energy metabolism. Thus, the 
effects of aflatoxins are seen in the inhibition of ATP generation, carbohydrate and 
lipid metabolism, mitochondrial structure and proteins synthesis. This chapter will 
focus on the mechanisms of aflatoxin-induced disruption of lipids, carbohydrates, 
and proteins metabolism, and how they affect the bioenergetic systems.
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1. Introduction
Aflatoxins constitute a cluster of mycotoxins that are derived from fungal metabo-
lites and are produced from diverse fungi species, especially Aspergillus [1]. They are a 
collection of closely linked heterocyclic compounds produced predominantly by two 
filamentous fungi, Aspergillus flavus and Aspergillus parasiticus [2]. These fungi are 
generally infectious to cereal produces like wheat, walnut, rice, cotton, peanuts, tree 
nuts and corn [3]. Aflatoxins are members of the difuranocoumarins with two signifi-
cant chemical structure series. These series include – (a) difurocoumarocyclopente-
none series (b) difurocoumarolactone series [4]. They are also known to cause severe 
health threats to humans and animals, thereby resulting to several complications like 
immunotoxicity, teratogenicity hepatotoxicity [5]. The key aflatoxins are B1, B2, G1, 
and G2. They are noted for their ability to induce huge amplification of inflammatory 
responses during the body’s, cutaneous and mucous respiratory cycles [6].
Food contamination by aflatoxin is a global concern particularly in the tropical 
and subtropical areas of the biosphere whereby warm temperatures and moisture 
enhance the growth of the Aspergillus fungi. Aflatoxins are well recognized carcin-
ogens specifically aflatoxin B1 (AFB1) to man and animals [4]. Currently, there are 
over 18 identified aflatoxins of which have been inadequately researched for their 
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occurrence, health-risk, and mechanisms of toxicity [7]. Owing to their extensive 
distribution in foods and feeds, Aflatoxins are the mycotoxins of utmost concern 
to food security. As a result of the public health fears that these toxicants add and 
their relationship with energy metabolism disruption, intensive findings have been 
carried out since their discovery to elucidate their interference with energy metabo-
lism and related concerns. The elucidation of these toxic features is a criterion to 
the design of therapeutic or protective means, and to sufficiently regulate their 
existence in foods and feeds [8].
Aflatoxins are extremely lipo-soluble compounds; hence they are readily 
absorbed via the gastrointestinal tract and respiratory tract which is usually their 
site of exposure into blood stream [9, 10]. Aflatoxins are found in human and ani-
mals based on two significant routes. They are either directly ingested as aflatoxin-
contaminated foods or inhaled from dust particles containing aflatoxin, usually 
expelled from industries and factories [9, 11]. In the body, aflatoxins are absorbed 
across the cell membranes where they enter the blood stream. From the blood 
stream, they are distributed in blood to various tissues, especially the liver which is 
the primary organ for metabolism of xenobiotic [11]. Aflatoxins are predominantly 
metabolized by the liver to yield a reactive epoxide intermediate, to be converted 
to a less harmful aflatoxin [12, 13]. In humans and predisposed animal species, 
aflatoxins, particularly Aflatoxin B1 (AFB1) are metabolized by cytochrome P450 
(CYP450) microsomal enzymes to yield aflatoxin-8, 9-epoxide. This metabolite is 
a responsive form that binds to DNA and to albumin usually in the blood serum, 
giving rise to adducts and thus triggering DNA impairment [12, 13].
2. Aflatoxin-induced disruption of energy metabolism
Aflatoxins interfere with normal metabolic processes. This interference 
encompasses the regulatory processes that occur throughout the progression of 
energy metabolism. Thus, the effects of aflatoxins are seen in the inhibition of 
ATP generation, carbohydrate and lipid metabolism, mitochondrial structure and 
proteins synthesis [14].
2.1 Inhibition of ATP generation
Aflatoxin B1 (AFB1), a member of the mycotoxins inhibits the electron transport 
chain (ETC) in the mitochondria which is a major tissue in energy metabolism. 
This inhibition occurs at both ADP-coupled and dDNDP-uncoupled stages [15]. At 
the cytochrome oxidase level and also between cytochrome b and c, AFB1 inhibits 
the electron transport chain. This however, can be reversed by the electron accep-
tor N′-tetramethylphenylenediamine (TMPD) [4]. AFB1 gives rise to reduction in 
cellular ATP synthesis. Consequently, an enlargement of the mitochondria develops 
and then sodium, potassium gradient is distressed within the cell [16].
2.2 Effect of aflatoxins on mitochondrial DNA
In the mitochondria, AFB causes radical structural changes [17–19]. Similarly, 
it causes mitochondrial directed apoptosis, consequently reducing their function 
[17, 18, 20]. The presence of aflatoxins may also disturb the telomere length and 
the different check points in the cell cycle, thereby initiating further harm to the 
regulatory processes of the cell cycle [20]. Furthermore, the degree of aflatoxin 
binding to DNA and its injured state, the stages of various protein modifications 
ranging from cell cycle and apoptotic pathways like protein kinase C (PKC), protein 
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kinase A (PKA), c-Myc, pRb, Ras, Bcl-2, p53, NF-kB, CKI, cyclins and CDK have 
significant implications to the life processes that may lead to the deregulation of cell 
proliferation resulting in the development of cancer [17, 18].
During hepatocarcinogenesis, the reactive aflatoxin-8,9-epoxide binds to 
mitochondrial DNA (mitDNA) when compared to nuclear DNA which prevents 
the production of ATP and FAD/NAD-linked enzymatic roles [19]. This results in 
the disturbance of mitochondrial functions in different body parts that require 
energy production in form of ATP [19]. Mitochondrial damage as a result of afla-
toxin influence can give rise to mitochondrial illnesses and may account for aging 
mechanisms [19]. Reports have stated that specific mitochondrial diseases occur 
as a result of the nucleus being able to detect energy deficits in its region. The 
nucleus then tries to recompense the ATP shortages by initiating the replication 
of any neighboring mitochondria; however, the feedback enhances replication 
of the original mitochondria that causes the energy deficit, thus, causing further 
complications [15]. Gene mutations are also seen when AFBI binds to DNA. This is 
such that structural alterations are formed, which results in length changes of the 
telomeres and the cell cycle check points [17, 18]. Also, the binding of Aflatoxin 
B1 to DNA at the guanine base in hepatic cells corrupts the genomic code that 
controls cell growth, thereby resulting in the formation of tumors [17–19]. The 
injury to mitochondrial DNA is initiated by mutations of mitochondrial mem-
branes resulting in heightened apoptosis as well as a disruption in the production 
of energy [18, 21, 22].
2.3 Carbohydrate and lipid metabolism
Metabolites of aflatoxin react with various cells, which in turn cause the inhibi-
tion of carbohydrate and lipid metabolism, as well as reduced liver function [23, 24]. 
The gluconeogenesis process is inhibited by AFB1. This is done by a reduction in the 
activity of glycogen synthase and transglycolase. This accounts for the rearrange-
ment and elongation of glycogen molecules [15]. Furthermore, AFB1 lowers the 
enzymatic function of phosphorglucomutase, which reversibly converts glucose −6- 
phosphate to glucose −1-phosphate. It also lowers the amount of glycogen present in 
the liver via the oxidation of glucose −6- phosphate [4]. A major interference caused 
by aflatoxins, especially AFB1, is the process of lipid deposition in the hepatic tissue. 
This can be attributed to impaired lipid transport in contrast with a prediction of 
increased lipid biosynthesis [15]. This lipid deposition in the hepatic tissue can be 
ascribed to a decreased oxidation of fat as the mitochondria are being compromised 
[15]. Also increased fat contents have been reported in plasma, liver, and adipose 
tissues in several studies [25–27] and linked to reduced oxidation of lipids and 
increased fatty acid synthesis, owing to altered expression of genes involved in lipid 
and lipoprotein metabolism, following AFB1 exposure [26].
2.4 Inhibition of proteins synthesis
Metabolites of Aflatoxins exhibit negative effects with diverse cells, which 
inhibit the synthesis of protein [28]. AFB1 directly inhibits the production of 
protein via the inactivation of enzymes involved in protein synthesis; that is 
initiation, transcription and translation processes of protein synthesis. Indirectly, 
AFBI inhibits protein production by changing the activity of DNA template. They 
obstruct pyrimidine and purines nucleosides subsequently leading to the inhibition 
of protein synthesis via the development of DNA, RNA and protein adducts [4].
Furthermore, the decrease in protein content of body tissues such as the kidney, 
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AFB1 is known to be mutagenic, immunosuppressive and teratogenic. These features 
may interfere with regular processes of protein production as well as inhibition of sev-
eral metabolic systems; consequently, initiating harms to several organs particularly the 
kidney, heart and liver [15, 30]. The precise reversible non-covalent and nonspecific-
irreversible covalent binding with aflatoxins can alter the activities and structure of 
proteins [21].
3. Conclusion
Aflatoxins, a cluster of mycotoxins produced by Aspergillus and other fungal 
species, are known to interfere with normal metabolic processes, thereby posing 
severe health threats to humans and animals. This chapter focused on mechanisms 
underlying aflatoxin-induced inhibition of energy metabolism, which involve dis-
ruption of lipids, carbohydrates, and proteins metabolism, as well as mitochondrial 
function, culminating in depletion of ATP pools.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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